Copied
 
 
Formål
Formål
Selskabets formål er direkte og indirekte at drive fabrikations- og handelsvirksomhed fortrinsvis med produkter indenfor sundhedssektoren, og yde service og rådgivning i tilknytning hertil, samt at drive forsknings-, udviklings- og investeringsvirksomhed og anden virksomhed, der efter bestyrelsens skøn har tilsvarende tilknytning.
Sidst opdateret den 03.12.2020 og angivet som gældende fra 03.12.2020 (1241 dage).
HistorikStartStop
Selskabets formål er direkte og indirekte at drive fabrikations- og handelsvirksomhed fortrinsvis med produkter indenfor sundhedssektoren, og yde service og rådgivning i tilknytning hertil, samt at drive forsknings-, udviklings- og investeringsvirksomhed og anden virksomhed, der efter bestyrelsens skøn har tilsvarende tilknytning03.12.2020
Selskabets formål er direkte og gennem datterselskaber at drive fabrikations- og handelsvirksomhed fortrinsvis med hjælpemidler inden for sygepleje- og hospitalssektoren samt at drive forskning & udvikling og investeringsvirksomhed i tilknytning hertil05.12.201302.12.2020
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 04.09.1957 (24342 dage).
Ingen historik.
Branche
Branche
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000).
Sidst opdateret den 05.03.2018 og angivet som gældende fra 01.01.2017 (2673 dage).
HistorikStartStop
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)01.01.2017
Fremstilling af farmaceutiske præparater (212000)01.01.201231.12.2016
Fremstilling af andre plastprodukter (222900)01.01.200831.12.2011
Fremstilling af andre plastprodukter i øvrigt (252490)04.09.195731.12.2007
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 04.09.1957 (24342 dage).
Ingen historik.
Revisor
Revisor
EY Godkendt Revisionspartnerselskab
Sidst opdateret den 07.12.2023 og angivet som gældende fra 07.12.2023 (142 dage).
Form
Virksomhedsform
60.
Sidst opdateret den 22.11.2013 og angivet som gældende fra 04.09.1957 (24342 dage).
Ingen historik.
Kontakt
HistorikStartStop
dkwebmaster@coloplast.com23.01.200001.11.2000
Virksomheden har ikke ændret Kontakt i sin levetid.
Ingen nuværende registrering.
Telefon
Telefonnummer
49111111.
Sidst opdateret den 01.04.2000 og angivet som gældende fra 23.01.2000 (8861 dage).
Ingen historik.
Navne
Ingen historik.
Binavne
Binavne
COLOMED RESEARCH CO. A/S.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 04.09.1957 (24342 dage).
HistorikStartStop
COLOMED RESEARCH CO. A/S04.09.1957
COLOPLAST INTERNATIONAL A/S04.09.1957
DANSK COLOPLAST A/S04.09.1957
SCANTAPE A/S04.09.1957
COLOMED RECEARCH CO. A/S04.09.195715.12.1993
DANSK COLOPLAST, AKTIESELSKAB04.09.195711.01.1993
Tegningsregel
Tegningsregel
Selskabet tegnes af to direktører i forening, af formanden i forening med en direktør eller af bestyrelsen i forening.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 05.12.2013 (3796 dage).
Fortolkning (3 tegningsmuligheder)
2 direktører +
formanden + 1 direktør
bestyrelsen
Ingen historik.
Ansatte
27.04.2024
Kapital
27.04.2024
Fra årsrapport
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class D
Grundlag for konklusion (revision):Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditor’s responsibilities for the audit of the Financial Statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Group in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark. We have also fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. To the best of our knowledge and belief, prohibited non-audit services referred to in Article 5(1) of Regulation (EU) No 537/2014 were not provided. Appointment We were first appointed auditors of Coloplast A/S on 12 June 1998 for the financial year 1997/98. We have been reappointed annually by shareholder resolution for a total period of uninterrupted engagement of 26 years including the financial year 2022/23.
Konklusion (revision):Our opinion In our opinion, the Consolidated Financial Statements (pages 83-139) give a true and fair view of the Group’s financial position at 30 September 2023 and of the results of the Group’s operations and cash flows for the financial year 1 October 2022 to 30 September 2023 in accordance with International Financial Reporting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act. Moreover, in our opinion, the Parent Company Financial Statements (pages 159-168) give a true and fair view of the Parent Company’s financial position at 30 September 2023 and of the results of the Parent Company’s operations for the financial year 1 October 2022 to 30 September 2023 in accordance with the Danish Financial Statements Act. Our opinion is consistent with our Auditor’s Long-form Report to the Audit Committee and the Board of Directors. What we have audited The Consolidated Financial Statements of Coloplast A/S for the financial year 1 October 2022 to 30 September 2023 comprise statement of comprehensive income, statement of cash flows, balance sheet, statement of changes in equity and notes, including summary of significant accounting policies. The Parent Company Financial Statements of Coloplast A/S for the financial year 1 October 2022 to 30 September 2023 comprise income statement, balance sheet and notes, including summary of significant accounting policies. Collectively referred to as the “Financial Statements”.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Report Management is responsible for Management’s Report (pages 4-82 and page 169). Our opinion on the Financial Statements døs not cover Management’s Report, and we do not express any form of assurance conclusion thereon. In connection with our audit of the Financial Statements, our responsibility is to read Management’s Report and, in doing so, consider whether Management’s Report is materially inconsistent with the Financial Statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. Moreover, we considered whether Management’s Report includes the disclosures required by the Danish Financial Statements Act. Based on the work we have performed, in our view, Management’s Report is in accordance with the Consolidated Financial Statements and the Parent Company Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement in Management’s Report.
Bibranche
Bibranche
Fremstilling af andre plastprodukter.
Sidst opdateret den 05.03.2018 og angivet som gældende fra 01.01.2017 (2673 dage).
HistorikStartStop
Fremstilling af andre plastprodukter01.01.2017
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil01.01.200831.12.2016
Medicinalvarefabrikker04.09.195730.12.2007
Børsnoteret
27.04.2024
Børsnoteret
true.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 01.01.2005 (7056 dage).
Ingen historik.
Hjemmeside
27.04.2024
Ingen nuværende registrering.
Ingen historik.